Clinical Study
Esophageal Carcinoma Histology Affects Perioperative Morbidity Following Open Esophagogastrectomy
Table 2
Adenocarcinoma and squamous
cell carcinoma tumor features and perioperative data.
| | | Adenocarcinoma, (%) | Squamous
cell carcinoma, (%) | -value |
| | T stage | | | | .2032 |
| | T0 | 5
(9.80%) | 2
(9.52%) | | | Tis | 2
(3.92%) | 0 | | | T1 | 5
(9.80%) | 4
(19.05%) | | | T2 | 10
(19.61%) | 2
(9.52%) | | | T3 | 27
(52.94%) | 9
(42.86%) | | | T4 | 2
(3.92%) | 4
(19.05%) | |
| | N stage | | | | .1933 |
| | N0 | 24
(47.06%) | 14
(66.67%) | | | N1 | 25
(49.02%) | 7
(33.33%) | | | N2 | 2
(3.92%) | 0 | |
| | Neoadjuvant therapy | | 18
(34.62%) | 9
(42.86%) | .5114 | | Weight loss | | 29
(55.77%) | 13
(61.90%) | .6301 | | Mean BMI | | 26.72 | 22.89 | .0299 | | Mean PNI | | 33.61 | 33.00 | .6921 | | Epidural anesthesia | | 44
(85%) | 18
(87%) | .78 |
| | Anastomosis | | | | .8892 |
| | Stapled | 17
(33.33%) | 6
(31.58%) | | | Sewn | 34
(66.67%) | 13
(68.42%) | | | Mean EBL | | 551.065 | 600.000 | .7626 | | Margin Pos | | 1
(2%) | 1
(4%) | .08 | | Time from OP to extubation | | 0.5
(0–48) | 1
(0–72) | .86 | | Complications | | 34
(65.38%) | 18
(85.71%) | .0693 |
| | Grade of complications | | | | .0053 |
| | 1 or 2 | 15
(44.12%) | 6
(35.29%) | | | 3, 4, or 5 | 19
(55.88%) | 11
(64.71%) | | | ICU stay days | | 23
(47.92%) | 16
(76.19%) | .0259 |
|
|
